Clinical Trial Update: Prospective Clinical Study of Nintedanib to Inhibit Endometrial Fibrosis to Prevent Recurrence of Uterine Adhesions [Phase 2, Phase 3]

View source ↗

Summary

Prospective clinical study evaluating nintedanib to inhibit endometrial fibrosis and prevent recurrence of uterine adhesions across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Adhesions

Drugs mentioned

• Nintedanib (nintedanib)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Uterine Adhesions | Phase 2, Phase 3 | Status: UNKNOWN